eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 05/10/2011
PIL Nexium I.V. 40mg Powder for solution for injection/infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Change to drug interactions
Updated on 26/07/2011 and displayed until 05/10/2011
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to storage instructions
  • Change to dosage and administration
Updated on 10/06/2011 and displayed until 26/07/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 03/11/2009 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to manufacturer contact details
Updated on 08/07/2009 and displayed until 03/11/2009
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 02/06/2009 and displayed until 08/07/2009
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to, or new, use for medicine
  • Change to storage instructions
  • Change to side-effects
  • Change to dosage and administration
  • Change due to user-testing of patient information
Updated on 14/08/2008 and displayed until 02/06/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 21/12/2007 and displayed until 14/08/2008
Reasons for adding or updating:
  • Change to drug interactions
Updated on 31/05/2006 and displayed until 21/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 25/05/2006 and displayed until 31/05/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to instructions about missed dose
  • Change to date of revision
Updated on 12/01/2006 and displayed until 25/05/2006
Reasons for adding or updating:
  • Change of contra-indications
  • Change to side-effects
  • Change to date of revision
Updated on 30/03/2004 and displayed until 12/01/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  esomeprazole sodium